Royal Swedish Academy of Sciences Announces Winner of 2026 Nobel Prize in Chemistry

Live News Network
1.4K followers
4 Video Views·Oct 7, 2026
The Royal Swedish Academy of Sciences announces the winner of the 2026 Nobel Prize in Chemistry on Oct. 7 in Stockholm, Sweden.
AI Generated·May contain errors
Good morning, good afternoon, good evening.
Welcome to the Royal Swedish Academy of Sciences and this press conference where we are going to present this year's Nobel Prize in Chemistry.
We will keep to our tradition and start in Swedish and then continue the presentation in English.
And of course you are welcome to ask questions in either of these languages.
My name is Ellen Måns and I am the Secretary General of the Swedish Academy of Sciences.
To my right is Professor Heiner Linke, Chairman of the Nobel Committee for Chemistry.
And to my left is Professor Peter Sommfay, Chairman of the Nobel Committee for Chemistry and an expert in the field.
My name is Ellen Måns and I am the Secretary General of the Swedish Academy of Sciences.
To my right is Professor Heiner Linke, Chair of the Nobel Committee for Chemistry.
And to my left is Professor Peter Sommfay, Member of the Nobel Committee for Chemistry and one of the experts in this field.
Årets pris handlar om att få kemin att välja spegelbild.
This year's prize is about making chemistry choose a mirror image.
Kungliga Vetenskapsakademien har beslutat att utdela 2026 års Nobelpris i kemi till Henri Cagan och Kenzo Tsouai
för upptäckten av icke-linjära effekter och autokatalys i asymmetrisk organisk syntes.
The Royal Swedish Academy of Sciences has decided to award the 2026 Nobel Prize in Chemistry to Henri Cagan and Kenzo Tsouai
for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis.
Henri Cagan was born in 1930 in Boulogne-Billancourt in France.
He is Professor Emeritus at Université Paris-Sud, now known as Université Paris-Saclay.
Kenzo Tsouai was born in 1950 in Hiroshima, Japan.
He is Professor Emeritus at Tokyo University of Science in Japan.
Professor Heiner-Linke will now give us a short summary.
This year's prize is about foundational chemistry.
Many molecules occur in two different versions.
Like my hands, they are one another's mirror image.
They look alike, but they are not identical.
I cannot put my hands on top of one another.
Such molecules are called chiral, from the Greek word for hand.
One well-known example is the molecule carvone, where the right-handed version smells like mint
and the left-handed version smells like the spice caraway.
The reason why we can perceive two versions of the same molecule in different ways
is because the receptors in our nose that recognize the molecules
are themselves built up from chiral building blocks.
In fact, all proteins in our bodies are built from only left-handed amino acids.
The right-handed versions hardly occur anywhere in nature.
So life as we know it is homochiral.
One important aspect of this has to do with pharmaceuticals.
Many active molecules in pharmaceutical applications are also chiral.
One hand might have the desired therapeutic effect,
while the other hand might have no effect or, in the worst case, might even be harmful.
This importance of chirality in chemistry raises an important question.
How can chirality emerge?
How does chemistry choose just one of the two mirror images?
I will try to explain this with this little fake experiment here.
Imagine I have a reaction that I want to take place
to create a molecule that can occur in two versions.
That's chiral.
Let's pretend the left-handed version is red and the right-handed version is yellow.
But my starting material in the middle is not chiral.
There is no left or right. I have nowhere to start from.
Which would mean in any normal chemical reaction
you would expect both versions to expect with the same probability.
You would get a mixture.
The question is then, how can a reaction be designed
to spontaneously create only one of the two mirror images
without involving any other chiral molecule?
It is this puzzle that this year's laureates have solved.
Their discoveries led to a chemical reaction
that spontaneously, without the involvement of other chiral molecules,
creates only one mirror image.
And this is the first time this has happened
since the processes that led to the chirality of life,
billions of years ago.
My colleague Peter Sommerfey is a professor of organic chemistry
and will now explain in detail how this worked.
Thank you, Heiner.
As Heiner explained, chirality is a very basic concept of organic chemistry.
Heiner also explained that organic molecules can be chiral
and exist as two non-identical mirror images called enantiomeres.
He also discussed the receptors in our noses.
The receptors are built by chiral amino acids.
And as an example, the amino acid alanine is shown up here.
The left-handed structure is the natural one
and is incorporated in our bodies
along with several other chiral amino acids.
And as a result, we are all chiral.
We have that in common.
The consequences of this should be appreciated.
So Heiner discussed the different smells of carbon
and a more dramatic example can be found among chiral drugs.
Here is one example where the left-handed enantiomere is a cough medicine
and its mirror image is a painkiller.
Please also note that the names of these drugs are mirror images of each other.
They are enantiomeres,
pretty much indicating the level of humor among organic chemists.
So if we appreciate that different enantiomeres can have different effects,
we need efficient methods for comparing them.
One such method is asymmetric catalysis.
Here we have a chiral molecule that is referred to as a chiral ligand
that combines with metal to form the chiral catalyst.
The catalyst will then interact with the substrate and the reagent
to form the product and release the catalyst.
And in this example, the left-handed version of the product is formed in excess.
For a long time, it was believed that if we mix the catalysts,
if we mix the left and right-handed catalyst,
the proportion of enantiomere in the product
would correlate linearly to that in the catalyst.
Kagan questioned this dogma
by assuming that two or more chiral ligands can interact with the metal.
Let's look at an example.
Here we will assume that two chiral ligands can interact with the metal
and we will also assume that we have 75% of the right-handed ligand
and 25% of the left-handed ligand.
If we then assume that they will combine with the metal statistically,
we will get 56% of the right-right catalyst,
6% of the left-left, and 38% of the left-right.
Now, the right-right and left-left catalysts are enantiomeres
and will behave identically, but the left-right is different.
For the sake of the argument, let's assume that the left-right catalyst
is much less reactive than the right-right and left-left.
That means that the reaction will face this situation.
We will have 90% of the right-right and 10% of the left-left.
The outcome from such a reaction will not be a straight line relationship,
but we will instead expect that we will get a higher proportion
of enantiomeres in the drug compared to what we have in the ligand,
which is referred to as a positive non-linear effect,
which is the red curve up here.
In an experiment, Kagan showed that this model is indeed correct.
Here, a sharp suboxidation, the straight line is the expected outcome
while the solid curve are the data that Kagan obtained,
indicating in this reaction a positive non-linear effect.
Kagan thus showed that it is possible to increase the chirality
compared to the catalyst used.
He also provided organic chemistry with a very powerful tool
for analysing asymmetric catalysis.
In this experiment, we see that we can increase the chirality
compared to what we have in the catalyst.
But can we create the chirality from nothing?
Kagan addressed this question by developing an asymmetric autocatalytic reaction,
a reaction in which the product from the reaction is its own catalyst.
Here, he started from a symmetrical starting material
and without using a chiral catalyst,
the catalyst is formed in the reaction as a mixture.
In that mixture, there will be a small, a tiny imbalance
between the two different enantiomeres
and the reaction is so powerful that it will selectively produce
a preference for either the right or left-handed product.
Indeed, he performed 37 experiments
and in 19 he obtained the left-handed product,
in 18 the right-handed product, but never as an equal mixture.
Zwei thus showed that it is possible to create a chirality imbalance
by using an autocatalytic reaction
and produce either the right or the left-handed product in preference.
In a subsequent experiment,
he started with a catalyst with a very low enantiomeric purity
and used that as a catalyst for this reaction
and obtained a product with a considerably higher enantiomeric exact.
He then used this product as a catalyst for a second reaction
and then repeated this procedure a third time
and obtained a product that is enantiomerically pure.
So, Zwei thus showed by his experiment
that it is possible to create a chirality imbalance
and to obtain an enantiomerically pure product.
The amplification of chirality in this experiment is 630,000 times
and ladies and gentlemen, you have to be aware
that this is probably the coolest experiment in organic chemistry.
Taken together, the ground-breaking discoveries
by Henri Cagan and Kenzo Zwei
have reshaped our understanding of molecular chirality,
how it is created, amplified and transmitted.
Thank you, Professor Sunfei.
So, we now have Professor Zwei with us on the phone from Hiroshima.
Good evening, Professor.
Good evening. Hello. I'm here. This is Kenzo Zwei.
Yes, Professor. How do you feel?
Well, I'm very excited to receive the very nice news of the Nobel Prize.
Of course, this is the most exciting day in my life.
I'm very glad to share the prize with Professor Henri Cagan,
such a famous organic chemist.
That's wonderful.
Thank you.
I'm sitting here in the beautiful session hall of the Royal Swedish Academy of Sciences
and at this press conference there are many interested journalists
from Swedish and international press.
And I wonder, are you ready to take some questions from them?
Yes, please. As far as I can answer.
I'm sure you will do great.
Yes.
So, please, Swedish television.
Good morning, Professor Zwei. My warmest congratulations to you.
What an honor.
Good morning. Thank you very much.
I mean, there are thousands of questions for you, obviously,
but I'm also curious about your feelings.
And I wonder, when you really sit with this, what has happened right now,
what are your feelings that come to you?
Well, in fact, we discovered this method of auto-catalysis in 1995
and since that time we have dealt with that reaction until today.
And we found out, I think, a lot of interesting things
about the origin of the homochirality.
And I'm very glad to receive the prize
because this field was recognized by the Nobel Prize Committee,
so the Society of Chirality.
There are many excellent researchers in this field,
so I'm very especially glad to receive this prize.
What are you most proud of in your own achievements?
This is because the discovery of asymmetric auto-catalysis,
which can act as a chiral catalyst for its own production
with amplification of enantiomeric excess.
And finally, without adding any chiral material,
without any effect of the chiral factor,
the reaction between pyrimidine-5-carbaldehyde and diisopropyl zinc
afforded the enantio-enriched pyrimidine alkanol
with detectable enantiomeric excess in one reaction,
R formation, and in another reaction, S formation.
That is the spontaneous asymmetric breaking of chirality in organic molecules.
We are very proud of the achievement of that reaction.
And also, starting with very low enantiomeric excess of the chiral auto-catalysis,
that is 0.00005% EE.
That is 5 million left and 5 million right,
and the difference is only several molecules.
And by repeating the reaction three times,
the enantiomeric excess reached up to greater than 99.5% EE.
So, this reaction may give some kind of explanation
that life is organized with essentially enantiopure organic compounds.
That is the origin of homochirality.
So, I think that is our important point.
More questions?
Yes, please.
Congratulations, Professor Sawai.
My name is Rieko Takahashi, Kyoto News Japan.
And I have two questions.
Would you tell us where you were when you got a call from the Nobel Committee?
And next question is,
we believe that this occasion draws great attention to your field of research once again.
So, how would you like your research and your field to develop in the coming years?
Excuse me, the first question, pardon.
Please say the first question.
The first question is,
would you tell us where you were when you got this calling from the Nobel Committee?
I was out for shopping nearby my house.
Is that the question?
Excuse me, what is the second question?
Yes, I repeat again.
We believe that this occasion draws great attention to your field of research once again.
So, how would you like your research and your field to develop in the coming years?
Yes, thank you for your question.
And it is a very important question.
This price is, of course, concerned with the chirality of molecules.
And as you know, the amino acid protein, our life is composed of L-amino acids and D-sugars.
And the problem is that the irregular mixture of L- and D-amino acids doesn't form a correct enzyme,
doesn't form a correct protein.
So, life cannot operate.
And that means that the homo chirality is essential for life.
And also the genes, DNA, D-sugars, to form correct helix, it is important that the sugars should be D.
So, the chirality problem is the very fundamental and essential prerequisite for the origin of life.
So, we are very glad to find some organic reaction to explain the homo chirality.
Of course, this is not the final answer.
This field should be forwarded, should be performed more and more to understand life.
And, of course, life science is very important, of course.
But in many cases, people take it for granted that amino acid is L.
So, they don't usually care L or D.
But the underlying aspect of life is that essentially all amino acids are L and D-sugars.
So, I think this prize, the prize this year, our prize, should make people to recognize the importance of the chirality of molecules.
So, I'm especially glad that it's effective.
And the important point next year should be, next year or other, also for the next generations,
the chirality, the study of the chirality should be more and more developed, I believe.
Thank you.
Okay, thank you.
Amelie Megner-Arn from TV4.
Professor Tsui, congratulations on the prize.
I was wondering which one is your favorite drug or favorite molecule that has been possible to produce thanks to your reaction?
Which one is the first one?
Which one?
I was not able to hear correctly.
Which one is then?
Pardon your question.
Which one?
Because of your reaction, it's possible to produce drugs, for instance, that have only one chirality.
And I wonder which one is your favorite drug or maybe your favorite molecule?
The question is, which one is your favorite molecule?
Favorite means that for asymmetrical autocatalysis or general question or favorite molecule,
we often use terimidylalcanol.
In this answer to your question, which is my favorite molecule for asymmetrical autocatalysis
or just regardless of asymmetrical autocatalysis, favorite molecule?
Excuse me.
Your question is the meaning of your question.
May I ask you?
Pardon your question.
Thank you so much.
I don't have time, I'm afraid.
Thank you anyway.
Sorry.
We're running a little bit short of time.
And this was the last question from the press for you, Professor Suwai.
So thank you so much.
And once again, my warmest congratulations.
And we look forward to meeting you in Stockholm in December for the Nobel Prize ceremony.
Thank you very much.
Thank you.
So let's move on to questions about the Chemistry Prize and the research involved.
To our committee members.
If you want to ask questions about their work, that's also possible.
Questions in English or Swedish, please.
Yes, please.
Hello, welcome.
I actually wanted to ask about the consequences of these discoveries.
It's been mentioned that on one hand it deals with understanding the chemistry of life.
On the other hand, it has many practical applications including pharmaceuticals and drug production.
What would you judge is the most important aspect of this discovery?
Do you want to answer that question, Professor Suwai?
Absolutely.
It's a very good question and I would like to give two answers.
In my opinion, the most important part is the contribution to our understanding about molecular chirality.
That is basic research.
In having said that it is basic research, it's also incorporated in every development of asymmetric catalysis in the industry.
I mean, it's in the backsides of our heads all the time.
It might be difficult to say that this drug or that drug was developed using this.
I would say all of them.
Because we use this as a tool.
We use this as an understanding how to develop catalysts, how they function.
Then the second part was about homo chirality.
That's an extremely difficult and I would say also sensitive question.
I mean, the homo chirality, how it arose.
I mean, that's four billion years ago.
Nobody will ever know for certain.
So, what Kenzo Suwai did here, he showed a model for how it can occur in a reaction vessel.
Which means that we've made it once, we've seen it happen.
And that by itself has revitalized that research area, which is now a very strong reach area.
Investigating and looking for plausible models for the origin of homo chirality.
But the Suwai reaction is not the origin of homo chirality.
Because they use reagents that were not available four billion years ago.
I hope you got an answer.
All right.
I think we're running a little bit short of time.
So, I'm sorry, but I will have to cut the questions here.
I want to thank you for your interest.
And I know that many of you have booked interviews with our experts.
So, we will proceed with that now.
I hope to see you back here at the Academy on Monday.
When we will present the Sveriges Riksbank Prize in Economic Sciences in the memory of Alfred Nobel.
Thank you.
